Menu
Create an Account
Log in
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Topics in Antiviral Medicine
™
December 2019/January 2020
Volume 27, Issue 4
Download here
, or select individual articles
Claim CME
Perspective
Advances Toward a Cure for HIV: Getting Beyond n=2
Jonathan Li, MD, MMSc
Therapeutic HIV Vaccines and Broadly Neutralizing Antibodies
Magdalena E. Sobieszczyk, MD, MPH
Aging and HIV Infection: Focus on Cardiovascular Disease Risk
Judith A. Aberg, MD
Immune Reconstruction Inflammatory Syndrome in HIV Infection: Beyond What Meets The Eye
Irini Sereti, MD, MHS
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
Home
Activities
Courses and Conferences
HIV In-Person and Virtual Courses
Earn CME From On-Demand Webcasts
The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Conference on Retroviruses and Opportunistic Infections
About IAS–USA Courses
Webinars
Upcoming Webinars
2022 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
IAS–USA Scientific Leadership Board
IAS–USA Governance
Core Faculty
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Practice Question of the Week
August 15, 2022: COVID-19 and Birth Outcomes
Which of the following findings was reported in the Tsepamo study, in which birth outcome surveillance was conducted among women in Botswana who were routinely screened for COVID-19 at delivery?
A. Maternal mortality was higher, with an age-adjusted risk ratio of 31.6, in women with COVID-19 than in women without COVID-19
B. Maternal mortality was higher during pre-Delta COVID-19 variant waves than during the Delta wave
C. Rates of any adverse birth outcome (defined as preterm delivery, small for gestational age, stillbirth, and neonatal death) were similar among infants born to women with COVID-19 and women without COVID-19
D. Rates of any adverse birth outcome were similar among infants born to women with HIV and who had COVID-19 and among infants born to women in the other comparison groups
Read the Article
Register for COVID-19 Course
View Related Resources
Leave Feedback
Subscribe
CLOSE